Lifecore Biomedical, Inc. (LFCR)
Trading
Quantity
Profitability
Ownership
Largest Insider Buys in Sector
LFCR Insider Trading Activity
LFCR Median Price and Trade Amounts History Chart
Statistics of Insider Transactions
Amount of Insider Buys and Sells
Buys | $7,297,578 | 3 | 100 |
Sells | $0 | 0 | 0 |
Related Transactions
| Kiper Christopher S | 1 | $6M | 0 | $0 | $6M | |
| WYNNEFIELD PARTNERS SMALL CAP VALUE LP I | 10 percent owner | 1 | $1.2M | 0 | $0 | $1.2M |
| Josephs Paul | Chief Executive Officer | 1 | $97,580 | 0 | $0 | $97,580 |
About Lifecore Biomedical, Inc.
Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization in the United States and internationally. It operates through Lifecore, Curation Foods, and Other segments. The Lifecore segment engages in the manufacture of pharmaceutical-grade sodium hyaluronate (HA) in bulk form, as well as formulated and filled syringes and vials for injectable products used in treating a range of medical conditions and procedures. It also provides services, including technology …
Insider Activity of Lifecore Biomedical, Inc.
Over the last 12 months, insiders at Lifecore Biomedical, Inc. have bought $7.3M and sold $0 worth of Lifecore Biomedical, Inc. stock.
On average, over the past 5 years, insiders at Lifecore Biomedical, Inc. have bought $6.15M and sold $0 worth of stock each year.
Highest buying activity among insiders over the last 12 months: Kiper Christopher S () — $6M. WYNNEFIELD PARTNERS SMALL CAP VALUE LP I (10 percent owner) — $1.2M. Josephs Paul (Chief Executive Officer) — $97,580.
The last purchase of 17,000 shares for transaction amount of $97,580 was made by Josephs Paul (Chief Executive Officer) on 2025‑01‑08.
List of Insider Buy and Sell Transactions, Lifecore Biomedical, Inc.
| 2025-01-08 | Josephs Paul | Chief Executive Officer | 17,000 0.0456% | $5.74 | $97,580 | +5.00% | ||
| 2024-10-03 | Kiper Christopher S | 1.46M 2.1987% | $4.10 | $6M | +33.55% | |||
| 2024-10-03 | WYNNEFIELD PARTNERS SMALL CAP VALUE LP I | 10 percent owner | 292,683 0.4397% | $4.10 | $1.2M | +33.55% | ||
| 2022-11-25 | WYNNEFIELD PARTNERS SMALL CAP VALUE LP I | director | 627,746 1.8334% | $7.97 | $5M | -14.58% |
Insider Historical Profitability
| Kiper Christopher S | 4084268 11.031% | $27.16M | 1 | 0 | ||
| WYNNEFIELD PARTNERS SMALL CAP VALUE LP I | 10 percent owner | 2607433 7.0423% | $17.34M | 2 | 0 | <0.0001% |
| Josephs Paul | Chief Executive Officer | 559717 1.5117% | $3.72M | 1 | 0 |
Historical Insider Profitability vs. Competitors
$2,051,022 | 1591 | -12.84% | $70.82M | |
$22,899,264 | 81 | 34.90% | $24.83M | |
$218,350,131 | 64 | 16.68% | $330.41M | |
$125,860,243 | 57 | -4.48% | $56.88M | |
$129,489,279 | 57 | 26.09% | $643.02M |
LFCR Institutional Investors: Active Positions
| Increased Positions | 41 | +46.59% | 5M | +26.18% |
| Decreased Positions | 37 | -42.05% | 1M | -6.38% |
| New Positions | 12 | New | 806,992 | New |
| Sold Out Positions | 19 | Sold Out | 437,737 | Sold Out |
| Total Postitions | 92 | +4.55% | 25M | +19.8% |
LFCR Ownership Change vs Market
Institutional Investor Ownership
| Wynnefield Capital Inc | $30,430.00 | 12.71% | 4.7M | -215,763 | -4.39% | 2024-12-31 |
| Legion Partners Asset Management, Llc | $28,674.00 | 11.98% | 4.43M | +1M | +49.3% | 2024-12-31 |
| Greenhaven Road Investment Management, L.P. | $23,396.00 | 9.77% | 3.62M | +1M | +62.25% | 2024-12-31 |
| 325 Capital Llc | $13,991.00 | 5.85% | 2.16M | +792,681 | +57.87% | 2024-12-31 |
| 22Nw, Lp | $11,356.00 | 4.74% | 1.76M | 0 | 0% | 2024-12-31 |
| Blackrock, Inc. | $10,459.00 | 4.37% | 1.62M | +103,535 | +6.84% | 2024-12-31 |
| Vanguard Group Inc | $9,903.00 | 4.14% | 1.53M | +215,437 | +16.38% | 2024-12-31 |
| Morgan Stanley | $4,821.00 | 2.01% | 745,185 | -31,505 | -4.06% | 2024-12-31 |
| Geode Capital Management, Llc | $4,437.00 | 1.85% | 685,746 | +88,061 | +14.73% | 2024-12-31 |
| Invesco Ltd. | $3,595.00 | 1.5% | 555,607 | +555,607 | New | 2024-12-31 |